Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0154
0.0000
(0.00%)
At close: September 6 at 1:51:16 PM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Fredrik Westman | CEO & MD | 957k | -- | 1972 |
| Mr. Gunnar Telhammar | Chief Financial Officer | -- | -- | 1961 |
| Arash Golshenas | Chief Technology Officer | -- | -- | 1984 |
Duearity AB (publ)
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help people predict the symptoms and manage their problems. The company was incorporated in 2020 and is based in Malmö, Sweden.
Corporate Governance
Duearity AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
TENDO.ST Tendo AB
1.4200
+6.77%
BIOVIT.ST Bio Vitos Pharma AB (publ)
0.2160
+60.59%
QLINEA.ST Q-linea AB (publ)
0.0356
-5.57%
QLIFE.ST Qlife Holding AB (publ)
1.9900
-3.40%
OSSD.ST OssDsign AB (publ)
11.58
-2.53%
XVIVO.ST Xvivo Perfusion AB (publ)
261.00
-6.12%
BJDX Bluejay Diagnostics, Inc.
3.5300
+7.29%
TMCI Treace Medical Concepts, Inc.
7.75
-1.02%
AEMD Aethlon Medical, Inc.
0.3504
+0.31%
NAOV NanoVibronix, Inc.
2.3600
+1.29%